Masayuki Enomoto

1.5k total citations
33 papers, 1.2k citations indexed

About

Masayuki Enomoto is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Masayuki Enomoto has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Masayuki Enomoto's work include Colorectal Cancer Surgical Treatments (8 papers), Inflammatory mediators and NSAID effects (6 papers) and Colorectal Cancer Screening and Detection (5 papers). Masayuki Enomoto is often cited by papers focused on Colorectal Cancer Surgical Treatments (8 papers), Inflammatory mediators and NSAID effects (6 papers) and Colorectal Cancer Screening and Detection (5 papers). Masayuki Enomoto collaborates with scholars based in Japan, France and United States. Masayuki Enomoto's co-authors include Kenichi Sugihara, Hiroyuki Uetake, Tetsuro Higuchi, Yoko Takagi, Labile Togba Soumaoro, Satoru Iida, Masahiro Muraoka, Michiko Miyaki, K Tanaka and Masashi Fukayama and has published in prestigious journals such as Cancer Research, Radiology and Clinical Cancer Research.

In The Last Decade

Masayuki Enomoto

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Enomoto Japan 14 552 437 364 234 222 33 1.2k
Motoi Kondo Japan 20 433 0.8× 419 1.0× 176 0.5× 314 1.3× 359 1.6× 37 1.3k
Kishore Guda United States 21 421 0.8× 880 2.0× 240 0.7× 301 1.3× 432 1.9× 47 1.6k
Seon Ae Roh South Korea 21 543 1.0× 628 1.4× 393 1.1× 138 0.6× 347 1.6× 57 1.3k
Merete Hektoen Norway 14 592 1.1× 739 1.7× 386 1.1× 178 0.8× 402 1.8× 22 1.5k
Shinji Ohki Japan 26 658 1.2× 589 1.3× 183 0.5× 218 0.9× 263 1.2× 90 1.4k
Norman Pratt United Kingdom 11 516 0.9× 284 0.6× 322 0.9× 124 0.5× 178 0.8× 14 958
B L Kemp United States 13 505 0.9× 690 1.6× 128 0.4× 85 0.4× 324 1.5× 20 1.4k
Do-Sun Byun United States 11 614 1.1× 1.3k 2.9× 189 0.5× 134 0.6× 229 1.0× 11 1.7k
Juan Moreno‐Rubio Spain 19 288 0.5× 634 1.5× 132 0.4× 66 0.3× 393 1.8× 35 1.1k
Sandrine Boyault France 14 351 0.6× 1.0k 2.3× 238 0.7× 142 0.6× 503 2.3× 20 1.7k

Countries citing papers authored by Masayuki Enomoto

Since Specialization
Citations

This map shows the geographic impact of Masayuki Enomoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Enomoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Enomoto more than expected).

Fields of papers citing papers by Masayuki Enomoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Enomoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Enomoto. The network helps show where Masayuki Enomoto may publish in the future.

Co-authorship network of co-authors of Masayuki Enomoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Enomoto. A scholar is included among the top collaborators of Masayuki Enomoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Enomoto. Masayuki Enomoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Hirotoshi, Masayuki Enomoto, Tetsuro Higuchi, et al.. (2011). Clinical Significance of Lymph Node Ratio and Location of Nodal Involvement in Patients with Right Colon Cancer. Digestive Surgery. 28(3). 190–197. 37 indexed citations
2.
Yamauchi, Shinichi, Hiroyuki Uetake, Akifumi Kikuchi, et al.. (2011). [A long-term survival case of neuroendocrine tumor of the sigmoid colon with multiple liver metastases].. PubMed. 38(12). 2271–3. 1 indexed citations
3.
Shimizu, Sayaka, Satoru Iida, Megumi Ishiguro, et al.. (2010). Methylated BNIP3 gene in colorectal cancer prognosis. Oncology Letters. 1(5). 865–872. 22 indexed citations
4.
Kobayashi, Hirotoshi, Masayuki Enomoto, Tetsuro Higuchi, et al.. (2009). A Case of Cecal Cancer with Large Abdominal Wall Abscess. The Japanese Journal of Gastroenterological Surgery. 42(10). 1603–1608. 1 indexed citations
5.
Iida, Satoru, Toshiaki Ishikawa, Masamichi Yasuno, et al.. (2008). Influence of methylation of the Wnt-antagonist SFRP1 and Dkk1 on outcome in colorectal cancer is reversed by K-Ras mutation. Cancer Research. 68. 990–990. 1 indexed citations
6.
Matsuyama, Takatoshi, Tetsuro Higuchi, Hirotoshi Kobayashi, et al.. (2008). Small Intestinal Stricture Caused by Non Steroidal Anti Inflammatory Drugs: Report of Two Cases. The Japanese Journal of Gastroenterological Surgery. 41(8). 1625–1630.
7.
Kobayashi, Hirotoshi, Kenichi Sugihara, Hiroyuki Uetake, et al.. (2008). Messenger RNA Expression of Vascular Endothelial Growth Factor and Its Receptors in Primary Colorectal Cancer and Corresponding Liver Metastasis. Annals of Surgical Oncology. 15(4). 1232–1238. 7 indexed citations
8.
Enomoto, Masayuki & Kenichi Sugihara. (2007). 1. Guidelines for Treatment of Colorectal Cancer. Nihon Naika Gakkai Zasshi. 96(2). 266–270. 7 indexed citations
9.
Kato, Shunsuke, Satoru Iida, Tetsuro Higuchi, et al.. (2007). PIK3CAmutation is predictive of poor survival in patients with colorectal cancer. International Journal of Cancer. 121(8). 1771–1778. 112 indexed citations
10.
Higuchi, Tetsuro, et al.. (2007). The Effect of Meloxicam, a Selective COX-2 Inhibitor, on the Microvasculature of Small Metastatic Liver Tumors in Rats. Japanese Journal of Clinical Oncology. 37(9). 673–678. 4 indexed citations
11.
Ishiguro, Megumi, Satoru Iida, Hiroyuki Uetake, et al.. (2006). Effect of Combined Therapy With Low-Dose 5-Aza-2′-Deoxycytidine and Irinotecan on Colon Cancer Cell Line HCT-15. Annals of Surgical Oncology. 14(5). 1752–1762. 40 indexed citations
12.
Soumaoro, Labile Togba, Hiroyuki Uetake, Yoko Takagi, et al.. (2006). Coexpression of VEGF-C and Cox-2 in Human Colorectal Cancer and its Association With Lymph Node Metastasis. Diseases of the Colon & Rectum. 49(3). 392–398. 63 indexed citations
13.
Kobayashi, Hirotoshi, Hiroyuki Uetake, Tetsuro Higuchi, Masayuki Enomoto, & Kenichi Sugihara. (2005). JTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in rats. BMC Cancer. 5(1). 26–26. 9 indexed citations
14.
Soumaoro, Labile Togba, Hiroyuki Uetake, Tetsuro Higuchi, et al.. (2004). Cyclooxygenase-2 Expression. Clinical Cancer Research. 10(24). 8465–8471. 229 indexed citations
15.
16.
Kojima, Kazuyuki, Masayuki Enomoto, & Kenichi Sugihara. (2002). Laparoscopic surgery for treatment of colorectal Cancer. 103. 64. 2 indexed citations
17.
Enomoto, Masayuki, et al.. (2002). Synthesis and Fungicidal Activity of α-Cyanoacetamide Derivatives: Discovery of a New Rice Blast Fungicide, Diclocymet (S-2900). Journal of Pesticide Science. 27(3). 257–266. 9 indexed citations
18.
Ono, Chihiro, Keigo Yoshinaga, Masayuki Enomoto, & Kenichi Sugihara. (2002). Discontinuous Rectal Cancer Spread in the Mesorectum and the Optimal Distal Clearance Margin in Situ. Diseases of the Colon & Rectum. 45(6). 744–749. 77 indexed citations
19.
Sugihara, Kenichi, et al.. (2000). A Study of Obstructive Colorectal Cancer.. The Japanese Journal of Gastroenterological Surgery. 33(6). 709–715. 4 indexed citations
20.
Miyaki, Michiko, Motoko Konishi, Rei Kikuchi-Yanoshita, et al.. (1994). Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.. PubMed. 54(11). 3011–20. 337 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motoi Kondo Breakdown of academic impact, for papers by Kishore Guda Breakdown of academic impact, for papers by Seon Ae Roh Breakdown of academic impact, for papers by Merete Hektoen Breakdown of academic impact, for papers by Shinji Ohki Breakdown of academic impact, for papers by Norman Pratt Breakdown of academic impact, for papers by B L Kemp Breakdown of academic impact, for papers by Do-Sun Byun Breakdown of academic impact, for papers by Juan Moreno‐Rubio Breakdown of academic impact, for papers by Sandrine Boyault
Rankless by CCL
2026